Industry & Business

SK Biotek is First South Korean Pharma Company to Invest in Ireland

 Breaking News
  • Kells Tech Hub Can Play a Major Role in Regional Enterprise Development Following 24 months of research, planning and development, the new Kells Tech Hub has been officially launched. The Kells Tech Hub is a world class regional enterprise development facility that will, through collaboration, clustering and creative thinking, help to support, promote and develop a culture of entrepreneurship in Kells, throughout Meath and across the wider [...]...
  • Three Early-Stage Start-ups Spin-in to NovaUCD Three early-stage start-ups have become the latest companies to spin-in to NovaUCD and join the community of entrepreneurs at University College Dublin’s (UCD) Centre for New Ventures and Entrepreneurs. Over 25 companies, employing some 200 people, are currently located at NovaUCD. The three companies, EPIC Conjoint, This is Seaweed and Travacoin, have located to NovaUCD in [...]...
  • Irish Exporters Association Launches 18th Export Industry Awards The Irish Exporters Association, in partnership with platinum sponsors KPMG and Trinity Business School, Trinity College Dublin, has announced that the 18th Export Industry Awards are now open for applications and launched the Alumni Programme for 2018. Companies can now submit their online application at http://www.irishexporters.ie/export-industry-awards/ to compete across 11 export industry related categories and be in with [...]...
  • Tourism Industry Very Upbeat on Prospects for 2018 Despite Wet and Cold Start to Year A difficult start to the year – due to weather conditions – somewhat dampened tourism sentiment for many sectors but most businesses report a positive outlook for the remainder of the year. This was one of the findings from the latest Fáilte Ireland Tourism Barometer, a survey of more than 500 tourism businesses around the country. [...]...
  • Skillnet Ireland – Without Upskilling, Businesses in Ireland Could Lose Competitive Advantage Skillnet Ireland (formerly Skillnets), the national agency for workforce development, has been launched at an event in Co Clare to promote upskilling within enterprise. Its mission is to facilitate increased participation in enterprise training and workforce learning in Ireland. Skillnet Ireland brings together 67 Skillnet Enterprise Learning Networks across the country under one unified brand [...]...

SK Biotek is First South Korean Pharma Company to Invest in Ireland

SK Biotek is First South Korean Pharma Company to Invest in Ireland
January 30
09:47 2018

The Irish and South Korean flags have been ceremoniously raised in the grounds of a pharmaceuticals manufacturing campus in Swords, Co. Dublin, which has been acquired by SK biotek, a global life sciences company, the first Korean pharma-company to invest in Ireland. SK biotek is a solely owned subsidiary of SK Group – a Top 100 Fortune 500 Global Company which employs 84,000 associates globally with annual revenue of €99.7 billion.

SK biotek announced the acquisition of the former Bristol-Myers Squibb API (active pharmaceutical ingredients) facility in Swords, Co. Dublin in June 2017 and completed the deal by year-end 2017.

Over 360 staff employed on Swords Campus, dedicated to API Operations, transitioned to SK biotek employment from 1st January 2018.

The acquisition of Swords Campus represents the progression of a growth plan for SK biotek to become a top tier global contract pharmaceuticals manufacturing firm by 2020.

SK biotek has confirmed that it plans to operate and develop Swords Campus as a stand-alone Contract Development Manufacturing Organization (CDMO), which will manufacture pharma products to specification for other pharmaceutical companies on a contract basis.  SK biotek has also confirmed that it intends to add marketing, research and development (R&D) talent, while investing to bring additional API manufacturing capacity to Swords Campus.

Speaking at the recent ceremonial flag-raising ceremony Dr. Junku Park PhD, Chief Executive Officer of SK biotek, commented: “With Ireland being at the forefront of global pharmaceutical manufacturing excellence, Swords Campus brings with it a strong legacy and rich history – which spans 50+ years of excellence in pharma production. The stellar reputation of Swords Campus both in manufacturing and regulatory affairs, and most importantly in its talented workforce who are joining us on the journey, will greatly help to drive our near-term ambition to become a leading global CDMO. We plan to enhance technological capability and manufacturing capacity and build long-term partnerships with existing and new customers and look forward to growing our presence in Swords in the coming years.”

Dr. Park added, “Our early experience of operating in Ireland in working through the acquisition has been very positive. Ireland has a welcoming business environment and a talented workforce. The work-place and cultural engagement has been highly positive and IDA Ireland’s assistance with guidance, introductions and local knowledge has also been very encouraging and much appreciated. The establishment of our first manufacturing campus outside of South Korea offers great opportunity for growth which will in turn create additional and exciting new opportunities for our staff in Swords.”

Minister of State Michael D’Arcy TD said: “This investment by SK biotek is a great vote of confidence for what Ireland has to offer, particularly our talented and flexible workforce.  The pharma sector is one of our fastest growing sectors and makes a huge contribution to the Irish economy in terms of jobs and manufacturing exports. The Government is keen to support dynamic pharma companies like SK biotek and I am pleased to hear of its ambitions for the future.”

CEO of IDA Ireland Martin Shanahan said: “Companies like SK biotek come to Ireland because of the high-level of plant engineering capabilities and our rich and strong pool of talent available in the sector. SK biotek has joined a world-class ecosystem of pharmaceutical manufacturing in Ireland and they will have the full support of IDA Ireland as they grow their operations here.”

CAPTION:

Dr Junku Park, PhD, CEO of SK Biotek, and Minister of State Michael D’Arcy TD.

About Author

admin

admin

Related Articles

New Subscriber





Subscribe Here



Advertisements



















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4